TNFR2 antagonist and agonist: a potential therapeutics in cancer immunotherapy.
Saved in:
| Title: | TNFR2 antagonist and agonist: a potential therapeutics in cancer immunotherapy. |
|---|---|
| Authors: | Quazi S; GenLab Biosolutions Private Limited, Bangalore, 560043, Karnataka, India. Colonel.quazi@gmail.com.; Department of Biomedical Sciences, School of Life Sciences, Anglia Ruskin University, Cambridge, UK. Colonel.quazi@gmail.com.; Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. Colonel.quazi@gmail.com. |
| Source: | Medical oncology (Northwood, London, England) [Med Oncol] 2022 Sep 29; Vol. 39 (12), pp. 215. Date of Electronic Publication: 2022 Sep 29. |
| Publication Type: | Journal Article; Review; Retracted Publication |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1559-131X |
|---|---|
| DOI: | 10.1007/s12032-022-01772-2 |
